Company intelligence / Profile preview

KYERON Medical Innovations

Enschede, Netherlands

Ownership: Private
Development stage: Other

Overview

KYERON manufactures and commercializes bone graft substitutes and biomaterial products. Products include HA/TCP granules with 83% porosity, NANO HA PASTE for injectable bone repair, AXOZ QS® cement, and wound management devices. Products are CE-marked (Class III) and distributed globally.

Therapeutic areas: DermatologyNeurologyRheumatologyOther
Modalities: Device (bone grafts, bone substitutes, injectable pastes, cements)
Industry: Implantable Medical Devices

Partnerships

Collagen Solutions (fibrous collagen powder supply partnership for wound management device development)

Beyond the preview

Go deeper on KYERON Medical Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KYERON Medical Innovations.

Explore the full profile